The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 13, 2021

Filed:

Mar. 07, 2018
Applicant:

Takeda Pharmaceutical Company Limited, Osaka, JP;

Inventors:

Masaki Daini, Kanagawa, JP;

Yuhei Miyanohana, Kanagawa, JP;

Satoshi Mikami, Kanagawa, JP;

Yuichi Kajita, Kanagawa, JP;

Masaki Ogino, Kanagawa, JP;

Tatsuki Koike, Kanagawa, JP;

Kohei Takeuchi, Kanagawa, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 207/12 (2006.01); C07D 405/12 (2006.01); C07D 403/12 (2006.01); C07D 405/14 (2006.01); C07D 401/14 (2006.01); C07D 417/14 (2006.01); C07D 403/14 (2006.01); C07D 493/08 (2006.01); C07D 487/10 (2006.01); C07D 498/10 (2006.01); C07D 471/04 (2006.01); C07D 413/12 (2006.01); C07D 491/107 (2006.01); C07D 487/08 (2006.01);
U.S. Cl.
CPC ...
C07D 207/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 413/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/08 (2013.01); C07D 487/10 (2013.01); C07D 491/107 (2013.01); C07D 493/08 (2013.01); C07D 498/10 (2013.01);
Abstract

The present invention provides a substituted pyrrolidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.


Find Patent Forward Citations

Loading…